Cargando…
Significance of KDM6A mutation in bladder cancer immune escape
BACKGROUND: Bladder cancer (BC) is the fourth most prevalent neoplasm in men and is associated with high tumour recurrence rates, leading to major treatment challenges. Lysine-specific demethylase 6A (KDM6A) is frequently mutated in several cancer types; however, its effects on tumour progression an...
Autores principales: | Chen, Xingxing, Lin, Xuehua, Pang, Guofu, Deng, Jian, Xie, Qun, Zhang, Zhengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164329/ https://www.ncbi.nlm.nih.gov/pubmed/34051747 http://dx.doi.org/10.1186/s12885-021-08372-9 |
Ejemplares similares
-
Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt/β-catenin pathway
por: Pang, Guofu, et al.
Publicado: (2019) -
Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines
por: Özden-Yılmaz, Gülden, et al.
Publicado: (2023) -
Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021) -
KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1
por: Liu, Lei, et al.
Publicado: (2021) -
Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer
por: Kong, Na, et al.
Publicado: (2022)